[1]
2018. ESTIMATION OF THE EFFECTIVENESS OF FINANCIAL COSTS FOR TARGETED THERAPY OF PATIENTS WITH METASTATIC KIDNEY CANCER. Voprosy onkologii. 64, 5 (May 2018), 657–663. DOI:https://doi.org/10.37469/0507-3758-2018-64-5-657-663.